chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am running a low temperature of 100; sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) and BODY TEMPERATURE ABNORMAL (I am running a low temperature of 100) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced ILLNESS (sick). On an unknown date, the patient experienced BODY TEMPERATURE ABNORMAL (I am running a low temperature of 100). On 28-Feb-2021, ILLNESS (sick) had resolved. At the time of the report, BODY TEMPERATURE ABNORMAL (I am running a low temperature of 100) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (Low) running a low temperature of 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Three (3) HPV, lot # (J013324) had been exposed to the out of range temperature and needed to be returned to clinic. These three vaccines were mistakenly and in administered to three (3) patients. Whoever the staff person was who administered 3 doses of the HPV that should not been used, clicked on the new lot number (J012212) instead of the old lot # (J013324). We have been unable to identify the three patients who received the vaccines exposed to the out of range temp. I have been identify the 12 patients who administered HPV vaccine between the dates of 2/12 - 12/18/14 under lot number (J012212).
Received Pfizer vaccine on 2/18/2021 and 3/16/2021. Tested positive for COVID-19 by PCR on 10/31/2021. Admitted to hospital on 10/31/2021 with fever and evidence of COVID-19 pneumonia. Also has L2-3 discitis/osteomyelitis, mitral valve endocarditis and epidural abscess. History of HTN, rheumatoid arthritis (on prednisone) and peripheral arterial disease.
A report has been received from a Pharmacist concerning a 3 year old, subject of unknown gender, who had been receiving Nasal FLUMIST (Intranasal). FLUMIST (Intranasal) started on 11-Feb-2014. The patient experienced FLUMIST was administered on FEB 11th however the vaccine expired FEB 10th which started on 11-Feb-2014. The outcome of the event of FLUMIST was administered on FEB 11th however the vaccine expired FEB 10th is unknown. The report was considered to be non-serious.
Immuns. x 2 on 10/19/11. Pt. called on 10/20/11 fever 101.0 --> 102.0, chills, back & legs hurt. Pt. took TYLENOL. Seen for OV. on 10/20. Right arm with erythema anterior, superior shoulder. No vesicles.
Body producing excessive saliva for the first 2.5 weeks. Than taste of metal. Followed horrific headaches. Been taking excedrine pills but can't take too many. Month of December, I have been experiencing severe memory loss. Co workers whom I worked for years, can't recall their name. Now my speech has been suffering. Can't articulate a conversion. Later this month, keep having random  nightmares consecutively.    Today is December 19, 2021. Spent the night and morning vomiting with migraine
16 wks after flu shot pt began with generalize lower extremity weakness with progression to respiratory arrest and intubation x 14 days. Dx with G.B.S. by ICU. Still in Rehab. Now with D.V.T.
Mom presented to clinic with reddened area approximatrely one inch below the injection site, smaller than the size of the patien's palm.  The area was marked with a marker and mom instructed to bring the patient back if the size increased or if swelling/pain occurred.  Mom returned to the clinic today (7/16/15) and the area inside the marked boundary was discolored, but not red.  The reddened area spread outside the marked area with warmth that was not noted yesterday. Pt denies pain or discomfort. The patient was assessed by the pediatrician who treated the patient for cellulitis.
The pt had a legal complaint. An attorney reported that a 5 year old female received Tetramune vaccine between 10/24/96 and 1/1/01. The attorney alleges that the vaccine contained "toxic" mercury in the form of thimerosal. The pt has not manifested any signs or symptoms that her parents, or her doctors, attribute to mercury exposure. This case was considered serious since metal poisoning was considered to be an "Other Medically Important Event" in this case. No additional information was available as of the date of this report.
Profound fatigue, lymphadenopathy,  severe generalized body soreness, headache, and diaphoresis  Arthropathy
within 3 minutes of getting the shot I got tired and had nausia after a hour I developed moderate pain in teh arm that I received the flu shot with
Only the liquid component of Menveo was administered; Only the liquid component of Menveo was administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 18-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA977A, expiry date 31-MAY-2024) for prophylaxis.   On 08-MAY-2023, the patient received Menveo. On 08-MAY-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Only the liquid component of Menveo was administered) and inappropriate dose of vaccine administered (Verbatim: Only the liquid component of Menveo was administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 12-MAY-2023 The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up. The patient received only the liquid component of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
This spontaneous report as received from a consumer refers to herself: a 69 year old female patient. Her medical history included degenerative hip. She had no drug reaction or allergies and reported no concomitant medications. On 13-MAR-2014 the patient was vaccinated with ZOSTAVAX, dose, route, site of administration, lot# not provided. On 13-MAR-2014, the patient woke up in the middle of the night and had a runny nose and scratchy, sore throat. She did not seek medical attention, was given no treatment for adverse effects and no lab diagnostic studies were performed. The symptoms were still running at the time of report and the patient's present status was reported as "not recovered". The relatedness between vaccination with ZOSTAVAX and reported adverse events was unknown. Additional information has been requested.
client is the doorman at the apartments ( building where a number of seniors reside). The Health Department was holding a COVID-19 vaccine clinic in the building. Client received his #2 Moderna vaccine about 10 :15 am, was observed x 15 mins, no reported side effects. the client was back at his desk in the area of the clinic, either sitting or standing in the area.  Almost an hour after receiving the vaccine, the client was standing but fell to the floor, hit his head and began having a grand mal seizure. We turned him on his side, he was unresponsive and in a seizure x 5 mins, 911 was called and responded. The superintendent of the building said the client had a seizure disorder.  Another co worker reported the client had had seizures at the building on 3 other occasions. We do not know what medication the client had taken that day. Client was in a postictal state and was transported by paramedics to the hospital.
Severe reaction : huge knot at injection site of right  arm, hot reddish& purple rash 5" x 5" -bruising  soreness, itching , site raised and swollen. I ran fever, chills, nausea , stomach cramping, lethargic no energy, headache. Received the shot on 7/23/19 and still have symptoms. Friday 7/26/19 was sick and went to bed and slept until 7pm on Saturday night 7/27/2019. I still do not feel good and  still have hurtful warm raised rash on arm with swelling and bruising one week later . I have been applying topical steroid cream, benadryl gel and using ice pack. I may see doctor tomorrow 7/30/19  if not better.
06/22/04 Patient presented to our ED via ambulance.  During his flight he noticed a few pustules were becoming larger and was quite itchy.  He showed them to his sargent who sent him to the ED for evaluation.  Presently is still here and has been seen by our ID doctor on 06/23/04 with probable generalized vaccinia.
pt presented to ER with positive COVID status from earlier yesterday; EMS called to home due to SOB and pt unresponsive; 02 saturation in 50s, placed on CPAP; SOB continued, pt intubated; kept on ventilator, pt required dialysis during this time; became hypotensive in spite of pressors being used, pt's condition declined and she died in the hospital
peripheraly neuropathy got worse; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 83-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: NEUROPATHY PERIPHERAL (medically significant), outcome "unknown", described as "peripheraly neuropathy got worse".  Clinical information: Caller stated that she had peripheral neuropathy for three years and it was much more since the booster. Had first booster and not second. She was reconsidering not getting the second because it was not reversible. She was already suffering, and she suspects it was from all the vaccines and the problem has become compoundable.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from medical assistant refers to unspecified number of patients of unknown age and gender. No current condition, drug allergic reactions and medical history were reported. On an unspecified dates, unspecified number of patients were vaccinated with PROQUAD (Merck) (strength, dose number, route, lot number and expiry date were unknown) that underwent a supported temperature excursion. No concomitant therapy was reported. No adverse experiences were reported. The outcome of event was unknown. No further information was provided. This is one of several reports received from the same source. Additional information has been requested.
red rash on back, face, back of upper arms & buttocks;over the course of the past few days covered entire body;eyes were also swollen sl;no problems breathing;No serious enough to go to ER;tx w/DPH;
Information has been received from 2 healthcare workers referring to a patient of unknown age and gender. The patient's medical history was not reported. On 24-MAR-2015, the patient was received improperly stored VARIVAX (Merck) (lot # K007979, exp date 03-JUN-2016, dose and route unknown. Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
pt recv vax 14NOV97 & was disoriented, nauseated, dizzy, head cloudy-lost equilibrium h/a;
Ct. reports immediate stinging pain in arm at vaccination site. States since then she has had stinging/pain off and on in arm. Numbness/tingling in fingers for the last 1 1/2 weeks and has difficulty lifting arm due to pain.
The early am (approximately 4 am) pt woke, felt light headed and experienced dry heaves. Report no pain, swelling or redness near injection site.
The first day, I was fine. The next day, I was fatigued. Over the weekend, I was very exhausted. I did not have any sweats or anything. Easter weekend, that's when it all hit. I woke up at midnight feeling ice cold to the point that I couldn't get up to get another blanket. I slept pretty much all day the next day. About a week or so later, I started noticed little red bumps on my ankles that itched. It then spread to my knees, elbows, and lower arms. That was towards the middle of April. I kind of ignored it. I began to wonder if I was having a reaction to the shot. I started hearing a ringing in my left ear and I am still experiencing that. My PCP told me to see a dermatologist after looking at the bumps because he didn't know. I saw the dermatologist on May 19, 2021. He told me to take Zyrtec 3xday. My PCP told me to take prednisone and it didn't do anything. I also saw an ENT on June 8, 2021. He did a hearing test and said there was some loss of hearing in my left ear. He put me on an extended period of prednisone. It did not make it go away in my case. I went back to see him about 2 weeks later. He recommended for me to have a cortisone injection into the ear drum or behind the ear drum. I decided not to do that. My PCP concurred with my decision. The red bumps are now sporadic. Every 3 or 4 days they show up. I think whatever is causing it is now moving through my system. I have noticed a change in my eye sight on the left side. I have a scheduled eye doctor appointment on July 6, 2021. I have noticed an all of a sudden difference in the last 6 weeks.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 31-AUG-2017, the patient was vaccinated with a dose of VARIVAX lot # M024702, expiry date 18-MAY-2018 (dose and route of administration were not reported). On 19-SEP-2017, the patient was vaccinated with a dose of ENGERIX-B (lot # GP7E7, expiry date 30-SEP-2017), and an expired dose of M-M-R II lot # M002418, expiry date 12-JAN-2017 (albumin status, dose and route of administration were not reported). No adverse effect was reported. No product quality complaint was involved.
Within 24 hrs of injection developed red, hot, itchy patch at injection site and then on general other sites on bilateral arms and forehead. After 6 days still present, took MEDROL dose pack. Rash gone 1 week after MEDROL.
This spontaneous case was reported by another health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Given a single monovalent Moderna vaccine in the past. Today the patient was administered a 0.2mL dose of the vial presentation of the dark pink cap and yellow label boarder vaccine) and NO ADVERSE EVENT (no adverse event) in a 1-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Apr-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 21-Apr-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Given a single monovalent Moderna vaccine in the past. Today the patient was administered a 0.2mL dose of the vial presentation of the dark pink cap and yellow label boarder vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Given a single monovalent Moderna vaccine in the past. Today the patient was administered a 0.2mL dose of the vial presentation of the dark pink cap and yellow label boarder vaccine) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Given a single monovalent Moderna vaccine in the past. Today the patient was administered a 0.2mL dose of the vial presentation of the dark pink cap and yellow label boarder vaccine). Patient was 21 months old.  Patient had single monovalent Moderna vaccine in the past as first dose. No concomitant medications were reported. No symptoms reported. No additional doses medications or treatments. Reporter did not allow further contact.
Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. The patient's last menstrual period was on 15-Nov-2020 and the estimated date of delivery was 13-Aug-2021. On 02-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 02-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided.
Fatigue.  Body aches. Nausea. Heart racing. Chills Nausea.
Increased chest pain, "itchy" at sight of injection without diaphoresis or SOB or dizziness, nausea or vomiting. Pt was sent to ER. Gave pt 0.3ml 1:1000 epinephrine SC in the right arm. Incident occurred 10 minutes after vaccine given. In follow-up, dated 12/18/00, this pt did spend the night at the hospital but was assured that the vaccine had no relationship to the chest pain.
Received vaccine at 10 AM at 2pm noticed "lump" in back of throat (sore throat) 4 pm tongue was "painful". 5pm "felt like upper lip was swollen. Stated no rash, hives, difficulty breathing. No redness or swelling at injection site.
This spontaneous report as received from a pharmacist refers to an unknown number of patients of unknown age and gender. The pharmacist reported that unknown number of patients might have received ZOSTAVAX (lot number unspecified) that as improperly stored from 20-MAY-2013 to 05-JUN-2013. No adverse effects reported. It was unknown if the patients had sought medical attention. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Follow up information has been received from a health professional refers to a 62 (also reported as 63) year old female patient. On 15-NOV-2012 at 10:03 the patient vaccinated subcutaneously in left arm with a dose of ZOSTAVAX (lot number H011048, exp. date not reported) (dose not reported) which was incorrectly stored. No adverse reactions reported. This is one of several reports from the same source. Additional information is not expected.
FEVER, CHILLS, NAUSEA, ITCHING AT INJECTION SITE, SWOLLEN AT INJECTION SITE, REDNESS AT INJECTION SITE, TIREDNESS.
No adverse effects reported; one expired dose of PROQUAD (N028447, Expiration: 9-APR-2019) was administered to one patient; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.      On 10-APR-2019, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD), subcutaneously, lot # N028447, with expiration date 09-APR-2019, for prophylaxis (strength, dose and frequency were not provided). No adverse effects were reported.
Woke up the next day with severe uterine pain. Pain in lower abdomen and uterus last for about 2 full weeks.
Significant swelling at injection site (goose egg size) redness, bruising and itchy rash extending from injection site down the arm to the wrist
On 3/27/21 this patient came to a COVID Vaccine clinic at our health center at that time the person may have received a dose of Pfizer vaccine diluted with Sterile Water rather than the saline solution diluent from the manufacturer. Our office was shipped 26 vials of vaccine and 25 vails or diluent as the State DOH reported there was a diluent shortage at the time. Under the direction of the stage DOH the sterile water solution was used. Later we were contacted to report this to both the patients and VAERS by the state DOH, as they later questioned their original desecion.   The were 30 to 36 doses drawn with this solution and this person is 1 of 72 others who may have had a dose of this mix
This spontaneous report as received from company representative via nurse practitioner refers to a patient of unknown demography. On an unknown date the patient was vaccinated with GARDASIL (dose and frequency were not reported) intramuscularly. The company representative reported off label use of GARDASIL (it cannot be determined if the product was GARDASIL or GARDASIL 9). The nurse reported that the patient received the third dose of GARDASIL only one month after the second dose was administered. No adverse effect reported. The outcome of off label use was unknown. The reporter did not provide the causality between the event and the suspect therapy. Additional information is not expected as the reporter did not wish to be contacted.
Started with a headache and nausea, then uncontrollable chills for the next 4-5 hours, I did not call my physician or go to an ER.
After administration of third shot, patient began to faint. Patient was guided onto exam table and did not completely lose consciousness. Medical Assistant reported the patient had "seizure like activity". Vitals were stable and Pediatrician was immediately on site.
Moderate to severe tinnitus. Consistent with 3 previous vaccines and COVID infection. See also VAERS reports: 414207 421687 750484   VAERS ID: 1185943
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: PT DEVELOPED MUSCLE SORENES FOR 2-3 DAYS AFTER VACCINE ADMINISTRATION. 4 DAYS AFTER VACCINATION, DEVELOPED BUMP AT UNDERARM ON SAME ARM AS INJECTION SITE, WHICH STARTED AS MARBLE-SIZED, AND CURRENTLY REDUCED IN SIZE, SIMILAR TO A PIMPLE.  PT ALSO DEVELOPED A RASH NEXT TO THE INJECTION SITE, STARTING ON 7/6/21, DESCRIBED AS AN OVAL PATCH, SIMILAR TO A BUG BITE, ITCHY, PAINFUL, & SWOLLEN. SYMPTOMS ARE STILL ONGOING/PERSISTENT, ALTHOUGH PT REPORTS THEY SEEM TO BE IMPROVING.